BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36876465)

  • 1. Mechanisms of cancer cell death induction by triptolide.
    AbdulHussein AH; Al-Taee MM; Radih ZA; Aljuboory DS; Mohammed ZQ; Hashesh TS; Riadi Y; Hadrawi SK; Najafi M
    Biofactors; 2023; 49(4):718-735. PubMed ID: 36876465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad targeting of triptolide to resistance and sensitization for cancer therapy.
    Hou ZY; Tong XP; Peng YB; Zhang BK; Yan M
    Biomed Pharmacother; 2018 Aug; 104():771-780. PubMed ID: 29807227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
    Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
    FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
    Woo Y; Lee HJ; Jung YM; Jung YJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
    Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
    PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in pancreatic cancer: an emerging mechanism of cell death.
    Mujumdar N; Saluja AK
    Autophagy; 2010 Oct; 6(7):997-8. PubMed ID: 20818166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide.
    Zhou ZL; Luo ZG; Yu B; Jiang Y; Chen Y; Feng JM; Dai M; Tong LJ; Li Z; Li YC; Ding J; Miao ZH
    Mol Cancer; 2010 Oct; 9():268. PubMed ID: 20932347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress on anti-tumor effects and mechanisms of triptolide and its combined application].
    Shi JF; Luo YY; Li JX; Luo RF; Chen L; Li J; Zhang JM; Fu CM
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3391-3398. PubMed ID: 31602900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways.
    Amini P; Moazamiyanfar R; Dakkali MS; Jafarzadeh E; Ganjizadeh M; Rastegar-Pouyani N; Moloudi K; Khodamoradi E; Taeb S; Najafi M
    Mini Rev Med Chem; 2023; 23(14):1461-1478. PubMed ID: 36658710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ.
    Cai J; Yi M; Tan Y; Li X; Li G; Zeng Z; Xiong W; Xiang B
    J Exp Clin Cancer Res; 2021 Jun; 40(1):190. PubMed ID: 34108030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of cancer cell death induction by paclitaxel: an updated review.
    Zhao S; Tang Y; Wang R; Najafi M
    Apoptosis; 2022 Oct; 27(9-10):647-667. PubMed ID: 35849264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
    Kiviharju TM; Lecane PS; Sellers RG; Peehl DM
    Clin Cancer Res; 2002 Aug; 8(8):2666-74. PubMed ID: 12171899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.
    Wang Y; Wang Y; Pan J; Gan L; Xue J
    Radiother Oncol; 2023 Jul; 184():109689. PubMed ID: 37150447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic cytotoxicity and apoptosis induced in human cholangiocarcinoma cell lines by a combined treatment with tumor necrosis factor-alpha (TNF-alpha) and triptolide.
    Panichakul T; Wanun T; Reutrakul V; Sirisinha S
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):167-73. PubMed ID: 12587840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives.
    Moazamiyanfar R; Rezaei S; AliAshrafzadeh H; Rastegar-Pouyani N; Jafarzadeh E; Mouludi K; Khodamoradi E; Zhaleh M; Taeb S; Najafi M
    Curr Pharm Des; 2023; 29(22):1713-1728. PubMed ID: 37185325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
    Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
    Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
    Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
    Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of cancer cell killing by metformin: a review on different cell death pathways.
    Wu XY; Xu WW; Huan XK; Wu GN; Li G; Zhou YH; Najafi M
    Mol Cell Biochem; 2023 Jan; 478(1):197-214. PubMed ID: 35771397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.